Gottlieb Addresses Coronavirus at Miami Breast Cancer Conference
March 9, 2020
Scott Gottlieb, MD, spoke about the spread of the novel coronavirus (COVID-19) during the keynote address at the 37th Annual Miami Breast Cancer Conference®.
Silas Inman
Axi-Cel Improves OS in Patients with Refractory B-Cell Lymphoma
December 7, 2019
The CAR T-cell therapy axicabtagene ciloleucel induced a median overall survival of 25.8 months for patients with refractory large B-cell lymphoma.
CC-93269 Demonstrates Promising Dose-Dependent Efficacy in Heavily Pretreated Myeloma
December 7, 2019
CC-93269 showed encouraging signs of dose-dependent efficacy with a safety profile that continues to be refined for patients with heavily pretreated relapsed/refractory multiple myeloma.
